MedPath

RCT of Cognitive therapy and Schematherapy for comorbid anxiety- and cluster C personality disorders.

Conditions
Anxiety Personality disorders co-morbidityangst persoonlijkheidsstoornis comorbiditeit
Registration Number
NL-OMON21667
Lead Sponsor
eiden UniversityPieter de la Court gebouwWassenaarseweg 522333 AK Leidentel: 071-5274003
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

Patients with an Axis I anxiety disorder (of panic disorder with/without agoraphobia, agoraphobia without a history of panic disorder, obsessive-compulsive disorder, social phobia, generalized anxiety disorder) as primary diagnosis, according to DSM-IV-TR.

Exclusion Criteria

Exclusion criteria are as follows:

1. Evidence of a mental retardation with an IQ less then 70

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
As primary outcome measure significant changes in general anxiety as assessed with the Beck Anxiety Inventory (BAI) (Beck & Steer, 1990) will be used.
Secondary Outcome Measures
NameTimeMethod
Secondary measures will assess:<br /><br>- more specific forms of anxiety (PSWQ, ASI, FQ, LSAS, PI-R) <br /><br>- general psychopathology (SCL-90R)<br /><br>- interpersonal problems (IIP, WAV)<br /><br>- personality pathology (ADP-IV, NEO-PI-R, NVM)<br /><br>- cognitive schemas and schema modes (SV-1, PDBQ, YPI, YRAI, YCI, SMI-R) <br /><br>- quality of life (WHOQOL-Bref, EQ-6D)<br /><br>- direct and indirect costs (TIC-P) <br /><br>- patient satisfaction (GGZ-thermometer). <br /><br />Remission from anxiety and AXIS II disorder is measured with the MINI and the SCID-II at post treatment and at follow up. Also an implicit computer task will be used to measure the decrease of personality pathology. To evaluate the efficacy of the treatment modalities a cost analysis will be performed using data from a medical consumption diary kept by the patient.
© Copyright 2025. All Rights Reserved by MedPath